Good morning, everyone, and how are you today? We hope the weekend was invigorating. Now, though, it is time to resume that familiar routine of meetings and deadlines. To cope, yes, we are quaffing a mandatory cup or two of stimulation. Our flavor today is Southern Pecan. Please join us, or grab a bottle of water, if you prefer. Whatever works, yes? Meanwhile, here are some tidbits to get you going. Monday is never easy. We hope you survive...
Affymax Rises On FDA Review Of Anemia Drug (The Street)
Bristol And J&J Form Hepatitis C Collaboration (Bloomberg News)
Abbott Dismisses Talk Of Selling Pharma Unit (Reuters)
Carl Icahn's Right-Hand Man Starts His Own Fund (Bloomberg News)
UK Launches $280M Fund To Boost New Medicines (Reuters)
Novartis Hopes Its Cancer Portfolio Will Impress (Dow Jones)
AstraZeneca To Share New Drugs With Academics (The Telegraph)
Shire Reaches Deal With FDA For New ProAmitine Trials (Pharma Times)
UK Budget Cuts May Thwart Cures For Killer Diseases (The Guardian)
Russian Drugmakers Question Government Pricing Strategy (Pharmcluster)
EDITOR'S NOTE: Please check this post for updates throughout the morning
sunrise pic thx to benimoto on flickr
1 Comment
http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/8934255/AstraZeneca-to-share-new-drugs-with-academics.html
Sick! "Do my clincial development, I don't know if this stuff is good for ANYthing, let'S see how we devide the booty..."